leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC
cell karyotype
cancer
cell lineage
mesoderm
cell sex
F
treatment
None
treatment description
No special treatment or protocol applies
antibody
NELFe
antibody antibodydescription
NELFe (RDBP). Antibody Target: NELFe
antibody targetdescription
NELFe (RDBP) is a part of the negative elongation factor complex which binds to RNAPII to suppress elongation.